bpc-157 arginate salt oral bioavailability BPC 157 UK: Acetate, Evidence & UK Peptides – It's Me & You What Is BPC-157 and How

It is not FDA-approved for general therapeutic use in humans, and the World Anti-Doping Agency added it to its Prohibited List in 2022

Laboratory research may investigate: enzymatic pathways involved in NAD+ synthesis and recycling interactions between NAD-dependent enzymes and metabolic signaling networks cellular responses to altered nicotinamide availability These investigations are typically conducted in controlled in vitro systems and molecular biology research platforms

Preclinical research evidence Animal Experiments Obese mouse model: After subcutaneous injection of AOD 9604 (250 g/kg) daily for 8 weeks, the body weight of obese mice decreased by 12%, the subcutaneous fat mass decreased by 25%, and the weight of epididymal adipose tissue decreased significantly

A 10mg vial at 2.5mg per week gives you exactly four doses over four weeks